Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs News Corporation Class A Common Stock (NWSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs News Corporation Class A Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while News Corporation Class A Common Stock trades at $29.01 (market cap $15.95B). The key difference: News Corporation Class A Common Stock is far larger — about 9.3× Nuvation Bio Inc. Class A Common Stock's market cap, and News Corporation Class A Common Stock pays a 0.7% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and News Corporation Class A Common Stock for 0 Days on average.
| NUVB | NWSA | |
|---|---|---|
Market Cap | $1.71B | $15.95B |
Volume | 5,448,712 | 3,890,129 |
Sector | Health | Media |
52-Week High | $9.54 | $31.19 |
52-Week Low | $3.41 | $22.40 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $16.77B |
Dividend Yield | — | 0.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About News Corporation Class A Common Stock
News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.
Read more on NWSA →
